Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,536,387
+$123,354 QoQ
Shares Held
1,656
-14.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#219
of 506 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PARTNERS CAPITAL INVESTMENT GROUP, LLP holds $5,273,927 across 5 Biotechnology names. ARGX ranks #2 (29.1% of the industry book) .
All Filings in ARGX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,536,387 | 1,656 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,413,033 | 1,935 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,815,611 | 2,159 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,584,410 | 3,504 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,931,474 | 3,504 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,808,311 | 8,124 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,650,035 | 4,309 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $5,040,259 | 9,298 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $4,225,573 | 9,826 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,229,242 | 5,662 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,411,846 | 11,597 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $6,254,516 | 12,722 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,090,263 | 13,061 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,478,043 | 14,703 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,109,012 | 16,126 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,299,252 | 9,345 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||